Funder
Alexion, AstraZeneca Rare Disease
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. WHO. Patient Engagement: Technical Series on Safer Primary Care. 2016 [cited 2022 10 May]; Available from: https://apps.who.int/iris/bitstream/handle/10665/252269/9789241511629-eng.pdf;sequence=1?msclkid=aca9d8afd03a11ec9e5780c6fbb59d2c
2. Davis RE, Jacklin R, Sevdalis N, Vincent CA. Patient involvement in patient safety: what factors influence patient participation and engagement? Health Expect. 2007;10(3):259–67.
3. Chalasani M, Vaidya P, Mullin T. Enhancing the incorporation of the patient’s voice in drug development and evaluation. Res Involv Engagem. 2018;4:1–10.
4. Hamakawa N, Kogetsu A, Isono M, Yamasaki C, Manabe S, Takeda T, et al. The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project. Res Involv Engagem. 2021;7(1):1–15.
5. Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov. 2017;3(2):76–83.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献